SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950134-06-009001
Filing Date
2006-05-08
Accepted
2006-05-08 08:15:19
Documents
6
Period of Report
2006-05-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a20222e8vk.htm 8-K 39944
2 EXHIBIT 3.1 a20222exv3w1.htm EX-3.1 14913
3 EXHIBIT 3.2 a20222exv3w2.htm EX-3.2 21183
4 EXHIBIT 4.1 a20222exv4w1.htm EX-4.1 262132
5 EXHIBIT 99.1 a20222exv99w1.htm EX-99.1 8647
6 GRAPHIC a20222a2022200.gif GRAPHIC 5204
  Complete submission text file 0000950134-06-009001.txt   355858
Mailing Address
Business Address 11588 SORRENTO VALLEY ROAD SUITE 17 SAN DIEGO CA 92121 (858) 794-8889
HALOZYME THERAPEUTICS INC (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32335 | Film No.: 06814756
SIC: 2836 Biological Products, (No Diagnostic Substances)